Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NLH-002
- Development stage
- Unknown
- Lead developer
- Hanwha Pharma
- Administration
- Oral
01
Overview
NLH-002 is a health functional food developed and launched by Han Wha Pharma. It is specifically formulated to provide antioxidant support and enhance immune system function. As a product within the Natura Life Health (NLH) series, it is regulated under South Korean health functional food standards, which require evidence of safety and functional efficacy for health maintenance claims. The product is designed to assist in maintaining cellular health by neutralizing free radicals and supporting the body's natural immune responses. It is part of Han Wha Pharma's broader pipeline of nutraceutical products aimed at improving general wellness through regulated dietary supplementation.
Beyond the preview
Go deeper on NLH-002.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NLH-002.